Federal regulators have begun a safety review of 2 RSV medicines used to protect infants, even though no safety problems have been reported.

Background. Transplacental respiratory syncytial virus (RSV) antibody transfer has been characterized, but little is known about the protective effect of breast milk RSV-specific antibodies. Serum ...

Young infants are protected against respiratory viruses by passive immunity in human milk, containing antibodies to these viruses because of maternal exposures. The fall in such protection as a result ...

Persons with self-reported immunocompromising conditions were enrolled in the antibody response trial. HealthDay News — For immunocompromised individuals, antibody response to respiratory syncytial ...

Immune responses to respiratory syncytial virus (RSV) vaccines tended to fall short in older people with weakened immunity, a study found. In 38 immunocompromised persons who received either the ...